Brain‐derived plasma p‐tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change
Brain‐derived p‐tau217 may reduce these off‐target effects of Alzheimer's disease pathology, but its performance against neuropathology has not been evaluated.